ABSTRACT ID HALL TITLE PRESENTER NAME TIME SLOT
MHC-224 E INOTUZUMAB OZAGOMYCIN IN COMBINATION WITH MINI-HYPER CVD REGIMEN WITH OR WITHOUT RITUXIMAB IN FIVE PATIENTS WITH RELAPSED REFRACTORY B - ACUTE LYMPHOBLASTIC LEUKEMIA. RITIKA PAHWA 8:00 - 10:00 AM
MHC-225 E TARGETED ORAL THERAPY – A GAME CHANGER IN THE MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA: A SINGLE TERTIARY HEALTH CENTRE EXPERIENCE TUSHAR PANDEY 8:00 - 10:00 AM
MHC-226 E EFFICACY AND SAFETY OF PONATINIB IN CHRONIC PHASE AND ACCELERATED PHASE CML PATIENTS- A RETEROSPECTIVE ANALYSIS FROM TATA MEDICIAL CENTRE,KOLKATA BAALAMURUGAN K T 8:00 - 10:00 AM
MHC-227 E THERAPEUTIC OUTCOME OF INTERCONTINENTAL-BERLIN-FRANKFURT-MÜNSTER(BFM) 2002 IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN A TERTIARY SINGLE CENTRE SETTING CHIRASREEE SANYAL 8:00 - 10:00 AM
MHC-228 E CLINICOPATHOLOGICAL SPECTRUM OF MULTIPLE MYELOMA IN AN INDUSTRIAL HOSPITAL OF CENTRAL INDIA. NADASHA KADEEJA 8:00 - 10:00 AM
MHC-229 E SURVIVAL OUTCOME OF ADOLOSCENTS AND YOUNG ADULTS WITH ALL WITH A PAEDIATRIC DERIVED BFM PROTOCOL SASADHAR PARIDA 8:00 - 10:00 AM
MHC-230 E IMPACT OF CARE DELIVERY AND LOSS OF FOLLOW-UP DURING COVID-19 PANDEMIC PERIOD AFFECTING THEIR OUTCOME IN KNOWN CML PATIENTS IN A TERTIARY CARE HOSPITAL FROM THE SOUTH INDIA PRAMOD KUMAR PAMU 8:00 - 10:00 AM
MHC-231 E ANALYSIS OF CYTOGENETIC ABNORMALITIES IN MULTIPLE MYELOMA WITH CLINICAL CHARACTERISTICS IN A TERTIARY CARE CENTER- 1YR STUDY SOUDAMINI MAHAPATRA 8:00 - 10:00 AM
MHC-232 E THE EARLY IMPRESSIONS WITH THE USE OF BCMA DIRECTED THERAPY: ELRANATAMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SAFETY & EFFICACY ANALYSIS IN A TERTIARY CANCER CENTRE. NOOPUR PATIL 8:00 - 10:00 AM
MHC-233 E SYNCHRONUS DISEASE: CHRONIC MYELOID LEUKEMIA WITH HYDATID CYST SURAJ VASUDEVAN 8:00 - 10:00 AM
MHC-234 E PREVALANCE OF HEMATOLYMPHOID NEOPLASM IN CHILDREN WITH SPECIAL REFERENCE TO IMMUNO-CYTOCHEMISTRY STUDY IN SOUTHERN ODISHA. AKASH KUMAR PUSTY 8:00 - 10:00 AM
MHC-235 E HIGH DOSE METHOTREXATE ADMINISTRATION IN ADULTS WITH HEMATO-LYMPHOID MALIGNANCIES WITHOUT MTX LEVELS MONITORING: A SINGLE CENTRE EXPERIENCE GAMA GOURAB 8:00 - 10:00 AM
MHC-236 E AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA – A SINGLE CENTER EXPERIENCE FROM NORTHERN INDIA NITIN GUPTA 8:00 - 10:00 AM
MHC-237 E SPECTRUM OF INFECTIONS AMONG FEBRILE NEUTROPENIC BLOOD CANCER PATIENTS: ANALYSIS OF CULTURE AND ANTIBIOTIC SENSITIVITY PATTERN IN GENERAL HEMATOLOGY WARD SAGNIK ROY 8:00 - 10:00 AM
MHC-238 E PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) AND ITS COMPLICATIONS DURING INDUCTION THERAPY IN PATIENTS OF ACUTE LEUKEMIA FROM A TERTIARY CARE HOSPITAL: A RETROSPECTIVE STUDY. DEBASHISH DEBTA 8:00 - 10:00 AM
MHC-239 E CLINICAL AND MICOBIOLOGICAL PROFILE OF BLOODSTREAM INFECTIONS IN HEMATOLOGICAL MALIGNANCIES: EXPERIENCE FROM A TERTIARY CARE CANCER CENTRE IN EASTERN INDIA RAJARSHI AICH 8:00 - 10:00 AM
BHL-301 F DIAGNOSTIC UTILITY OF PLATELET VOLUME INDICES IN PATIENTS OF DYSLIPIDEMIA: A PROSPECTIVE STUDY IN A MEDICAL COLLEGE IN EAST INDIA SAYANTANI GHOSH HAZRA 8:00 - 10:00 AM
BHL-302 F ROLE OF INFLAMMATORY MARKERS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION AT TERTIARY CARE HOSPITAL: A CROSS-SECTIONAL OBSERVATION. DIVYA TIWARI 8:00 - 10:00 AM
BHL-303 F EVALUATION OF HEMATOLOGICAL PARAMETERS IN CHRONIC LIVER DISEASE TANVI CHAUBEY 8:00 - 10:00 AM
BHL-304 F THE PROGNOSTIC VALUE OF NLR, LMR AND PMR IN PATIENTS WITH ABNORMAL UTERINE BLEEDING KRITI OJHA 8:00 - 10:00 AM
BHL-305 F D-DIMER AND FIBRINOGEN LEVELS AS ADDITIONAL DIAGNOSTIC MARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROME KRISHNA KAUSHIK 8:00 - 10:00 AM
BHL-306 F EVALUATION OF MANUAL METHODS VS AUTOMATED ANALYZER IN REPORTING ROUTINE HEMATOLOGICAL PARAMETERS- A STUDY AT A MEDICAL COLLEGE OF EASTERN INDIA SAYANTANI GHOSH HAZRA 8:00 - 10:00 AM
BHL-307 F NOT ALL THROMBOCYTOPENIA IS ITP: LOOK HARDER, DIG DEEPER NIPUN MADHAV 8:00 - 10:00 AM
BHL-308 F EFFICACY OF HBA1C TEST IN POPULATION WITH HEMOGLOBIN VARIANTS – A STUDY FROM NORTHERN DISTRICTS OF WEST BENGAL MADHURIMA DAS 8:00 - 10:00 AM
BHL-309 F CLINICAL AND HEMATOLOGICAL PARAMETERS IN UNCOMMON DOUBLE HETEROZYGOUS HAEMOGLOBINOPATHIES HEMOGLOBIN DE AND HEMOGLOBIN SE- AN OBSERVATION FROM NORTHERN DISTRICTS OF WEST BENGAL MADHURIMA RAY 8:00 - 10:00 AM
BHL-310 F UTILITY OF VOLUME CONDUCTIVITY SCATTER PARAMETERS IN SPECTRUM OF CORONARY ARTERY DISEASE PATIENTS MANSI MEHROTRA 8:00 - 10:00 AM
BHL-311 F DIAGNOSTIC UTILITY OF BONE MARROW PARTICLE SQUASH SMEARS IN ROUTINE PRACTICE: A VALIDATION STUDY AJIT SAHU 8:00 - 10:00 AM
BHL-312 F CLINICAL PROFILE AND LABORATORY PARAMETERS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DIVIYA N 8:00 - 10:00 AM
BHL-313 F A CRITICAL COMPARISON BETWEEN PLATELET COUNTING USING PLATELET FLUORESCENCE AND PLATELET IMPEDANCE METHOD MANISHA PANDA 8:00 - 10:00 AM
BHL-314 G A PERFORMANCE VERIFICATION OF PLATELET COUNTING FROM PERIPHERAL BLOOD FILMS USING AUTOMATED DIGITAL MICROSCOPY - SYSMEX DI-60 ANURADHA MOHAN 8:00 - 10:00 AM
BHL-315 G BONE MARROW EVALUATION IN GERIATRIC PATIENTS –HEMATOPATHOLOGICAL PROFILE AT A TERTIARY CARE CENTRE RACHEL TIRKEY 8:00 - 10:00 AM
BHL-316 G PANCYTOPENIA AND BI-CYTOPENIA : A STUDY ON POSSIBLE ETIOLOGIES AND HEMATOLOGICAL PROFILE DEEPIKA MISHRA 8:00 - 10:00 AM
BHL-317 G TO STUDY THE HAEMATOLOGY LABORATORY QUALITY MANAGEMENT SYSTEM AS PER ISO15189 IN MEDICAL LABORATORIES WITH LIMITED RESOURCES IN SEVERAL INDIAN STATES. MANIKCHANDRA TIWARI 8:00 - 10:00 AM
BHL-318 G ROLE OF HFLC AND SCATTERGRAM IN DIAGNOSIS OF DENGUE SANDIPA CHAKRABORTY 8:00 - 10:00 AM
BHL-319 G HETEROGENEITY IN HEMATOLOGICAL AND THROMBOTIC PARAMETERS OF NATIVE HIGH-LANDERS AND LOW-LANDERS ITI GARG 8:00 - 10:00 AM
BHL-320 G A SYNONYMOUS MUTATION [?- CODON 16 (C>T), HBB: C.51C>T] RESPONSIBLE FOR THALASSEMIA AMONG INDIAN PATIENTS MANJU GORIVALE 8:00 - 10:00 AM
BHL-321 G COMPARATIVE STUDY OF HEMOSTATIC PROFILE BETWEEN CONVENTIONAL METHODS AND ‘SONOCLOT COAGULATION AND PLATELET FUNCTIONAL ANALYSER’ IN PATIENTS WITH SEPTICEMIA ANAGHA N V 8:00 - 10:00 AM
BHL-322 G STUDY OF PLASMA D-DIMER LEVEL AND MEAN PLATELET VOLUME IN PATIENTS WITH CHRONIC URTICARIA AND THEIR CORRELATION WITH DISEASE SEVERITY KAUSHAL KUMAR 8:00 - 10:00 AM
BHL-323 G UTILITY OF IMMATURE RETICULOCYTE FRACTION IN EVALUATING RESPONSE TO TREATMENT IN MEGALOBLASTIC ANEMIA: A PILOT STUDY LIKHA YAZUR 8:00 - 10:00 AM
BHL-324 G A STUDY OF ETIOLOGICAL AND HEMATOLOGICAL PROFILE IN PATIENTS OF PANCYTOPENIA IN A TERTIARY CARE HOSPITAL IN NORTH INDIA ANUJ CHACHRA 8:00 - 10:00 AM
BHL-325 G EVALUATION OF HIGH FLUORESCENT LYMPHOCYTE COUNT OF SYSMEX XN SERIES AS A PREDICTOR OF DENGUE INFECTION MANUSHREE SAXENA 8:00 - 10:00 AM
BHL-326 G EVALUATION OF UTILITY OF CD157 IN DETECTION OF PNH CLONES USING FLAER-BASED FLOW CYTOMETRY ASSAY AT A TERTIARY HEALTH CENTRE IN WESTERN INDIA. NEHA SINGH 8:00 - 10:00 AM
BHL-327 H SONOCLOT – MORE EFFECTIVE TOOL FOR DETECTING PLATELET FUNCTIONAL DISORDERS VANI KRISHNAMURTHY 8:00 - 10:00 AM
BHL-328 H ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)-BASED CLOT WAVEFORM ANALYSIS IN LIVER DISEASE AND SEPIS/DISSEMINATED INTRAVASCULAR COAGULATION (DIC) NANCY MAHAPATRA 8:00 - 10:00 AM
BHL-329 H NEUTROPHIL CD64 AS AN EARLY DIAGNOSTIC TOOL FOR SEPSIS IN ICU PATIENTS AMIT NISAL 8:00 - 10:00 AM
BHL-330 H ASSOCIATION OF PLATELET INDICES LIKE MPV AND PDW WITH SEPSIS AND ITS CORRELATION WITH SOFA SCORE. PRASIDHA SETHI 8:00 - 10:00 AM
BHL-331 H VALIDATION OF A POINT OF CARE RAPID DIAGNOSTIC KIT FOR THE DETECTION OF SICKLE CELL DISEASE NISHITA NAYAK 8:00 - 10:00 AM
BHL-332 H MOLECULAR HLA DIVERSITY IN INDIAN POPULATION CATEGORIZED BASED ON GEOGRAPHICAL REGIONS AND THE PROBABILITY OF FINDING MATCHED DONORS: A PERSPECTIVE FROM UMBILICAL CORD BLOOD BANK SUREKA RAJENDRAN 8:00 - 10:00 AM
BHL-333 H RETICULOCYTE HEMOGLOBIN CONCENTRATION AS AN EARLY MARKER TO DETECT IRON DEFICIENCY IN TERM LOW BIRTH WEIGHT NEONATES. MUSKAN SACHDEVA 8:00 - 10:00 AM
BHL-334 H COMPARISON OF HPLC FINDINGS BETWEEN BIO-RAD VARIANT-II AND TOSOH HLC-723G11 AS DIAGNOSTIC TOOL FOR HAEMOGLOBINOPATHIES. SOMA PRADHAN 8:00 - 10:00 AM
BHL-335 H EVALUATION OF HEPATIC IRON OVERLOAD BY R2* MRI IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA AND ITS CORRELATION WITH SERUM FERRITIN ANANNYA BHAKAT 8:00 - 10:00 AM
BHL-336 H ROLE OF RBC INDICES IN EARLY DETECTION OF SICKLE CELL DISEASE IN PEDIATRIC TRIBAL COMMUNITIES OF SOUTHERN ODISHA. ANJALI SHINDE 8:00 - 10:00 AM
BHL-337 H ROLE OF RBC INDICES IN DIFFERENTIATING BETA THALASSEMIA TRAIT FROM IRON DEFICIENCY ANEMIA. RAJESH KUMAR 8:00 - 10:00 AM
BHL-338 H HAEMATOLOGICAL INDICES IN DIAGNOSING BETA THALASSEMIA TRAIT IN RESOURCE POOR SETTING HEMA LATHA GUNDU 8:00 - 10:00 AM
BHL-339 H DETERMINATION OF PLATELET FUNCTION TEST USING AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY ON THE ROUTINE COAGULATION ANALYZER SYSMEX CS-2500, A SINGLE INSTITUTIONAL EXPERIENCE FROM EASTERN INDIA. SAYANDEEP GHOSH 8:00 - 10:00 AM
MHL-401 E DOES EXPRESSION OF CD25 BY FLOW CYTOMETRY CORRELATES WITH BCR::ABL1 POSITIVITY IN CASES OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. TEJASVI SHARMA 5:00-7:00 PM
MHL-402 E FREQUENCY AND OUTCOME OF 1P32 DELETION IN NEWLY DIAGNOSED MULTIPLE MYELOMA NITHYE PARVATHY EZHUMALAI SRINIVASAN 5:00-7:00 PM
MHL-403 E ROLE OF THE IMMUNE CELL MICROENVIRONMENT IN THE PERSISTENCE OF MEASURABLE RESIDUAL DISEASE IN CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA SHUBHAM PAWAR 5:00-7:00 PM
MHL-404 E FLOW CYTOMETRY IMMUNOPHENOTYPE AND EXPRESSION OF ABERRANT MARKERS IN 35 CASES OF ACUTE LEUKEMIA: A ONE YEAR STUDY IN A TERTIARY CARE GOVERNMENT HOSPITAL. GARIMA DHULL 5:00-7:00 PM
MHL-405 E CLINICOHEMATOLOGICAL AND IHC PROFILE IN 45 CASES OF LYMPHOMA: A 3 YEAR PILOT STUDY FROM A GOVERNMENT HOSPITAL IN AN INDUSTRIAL BELT IN INDIA. SUJATA RAYCHAUDHURI 5:00-7:00 PM
MHL-406 E HIGH FLUORESCENCE CELL COUNT IN BODY FLUIDS USING AUTOMATED HEMATOLOGY ANALYZER- A SCREENING TOOL FOR MALIGNANCY ALICE XALXO 5:00-7:00 PM
MHL-407 E NOVEL MUTATIONS IN ACUTE ERYTHROID LEUKEMIA- A CASE REPORT. PRIYAVADHANA BALASUBRAMANIAN 5:00-7:00 PM
MHL-408 E DETECTION AND MONITORING OF RESIDUAL DISEASE IN PATIENTS WITH B LYMPHOBLASTIC LEUKEMIA RECEIVING ANTI-CD19 THERAPY SAMYUKTHA ABBAGANI 5:00-7:00 PM
MHL-409 E FLOW CYTOMETRIC EVALUATION OF TRBC1 FOR ASSESSING CLONALITY IN TCR??+ MATURE T-CELL NEOPLASMS: AN EXPERIENCE FROM A TERTIARY CARE CENTER SAMBHU NATH BANERJEE 5:00-7:00 PM
MHL-410 E ACUTE MYELOID LEUKEMIA WITH RAM IMMUNOPHENOTYPE: NEW KID ON THE BLOCK! GARIMA GOEL 5:00-7:00 PM
MHL-411 E FORECASTING MYELODYSPLASTIC SYNDROME (MDS) THROUGH CELL POPULATION DATA PARAMETERS: AN INNOVATIVE METHODOLOGY. PRATYUSH MISHRA 5:00-7:00 PM
MHL-412 E CYTOGENETIC LANDSCAPE OF RELAPSED PAEDIATRIC PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: DECODING CLONAL EVOLUTION SIMPY RAJ 5:00-7:00 PM
MHL-413 E ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE- CLINICOPATHOLOGICAL AND IMMUNOPHENOTYPIC CORRELATION: A 3 YEAR STUDY IRENGBAM NIVEDITA DEVI 5:00-7:00 PM
MHL-414 F CD9/P24 EXPRESSION ON LEUKEMIC MYELOID BLASTS IS ENRICHED IN ADVERSE RISK AML PREETI KHOKHAR 5:00-7:00 PM
MHL-415 F CLINICOPATHOLOGICAL AND IMMUNOPHENOYYPIC PROFILE OF T-ALL DIAGNOSED IN A TERTIARY HOSPITAL DURING A PERIOD OF 3 YEAR WITH A EMPHASIS ON ETP-ALL TANIYA SHARMA 5:00-7:00 PM
MHL-416 F EXTRAMEDULLARY BLAST DEPOSITS OF MYELOID MALIGNANCIES: CASE SERIES OF 5 CASES REPORTED IN A TERTIARY CARE INSTITUTE. RACHANA MEENA 5:00-7:00 PM
MHL-417 F AN INTRIGUING CASE OF PNH COMPLICATED WITH ACUTE MYELOID LEUKAEMIA. HARSH BHALODIYA 5:00-7:00 PM
MHL-418 F FLOWCYTOMETRIC ANALYSIS OF CD200 AND CD79B EXPRESSION IN DIFFERENTIATING CHRONIC LYMPHOCYTIC LEUKEMIA FROM OTHER CHRONIC LYMPHOPROLIFERATIVE DISORDERS ANANYA HALDER 5:00-7:00 PM
MHL-419 F BASOPHIL-LINEAGE COMMITMENT MARKER CD203 PREDICTS HIGHER INTRACRANIAL BLEEDING RISK AND HIGHER PROGRESSION TO DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) VANDANA PURI 5:00-7:00 PM
MHL-420 F HYPEREOSINOPHILIA IN A PATIENT WITH MULTIPLE MYELOMA PRISHA NANKANA 5:00-7:00 PM
MHL-421 F BONE MARROW MORPHOLOGY AND IMMUNOHISTOCHEMISTRY ARE RELIABLE TOOLS TO DIAGNOSE WALDENSTORM MACROGLOBULINEMIA: A SERIES OF THIRTEEN CASES FROM A TERTIARY CARE CENTRE. MANISHA PANDA 5:00-7:00 PM
MHL-422 F SPECTRUM OF HISTOPATHOLOGICAL DIAGNOSIS OF LYMPH NODE BIOPSIES AND UTILITY OF IHC : A 2.5 YEAR RETROSPECTIVE STUDY FROM SINGLE CENTER TERTIARY INSTITUTION GARIMA PATHAK 5:00-7:00 PM
MHL-423 F ABERRANT IMMUNOPHENOTYPES WITH SPECIAL REFERENCE TO TWO NOVEL MARKERS - CD123 AND CD25 IN ACUTE LEUKEMIA -A STUDY IN EASTERN INDIA PRANNOY DAS 5:00-7:00 PM
MHL-424 F A STUDY OF CLINICOPATHOLOGICAL CHARACTERISTICS OF ETP-ALL DIAGNOSED BY APPLYING TCCSG FLOW CYTOMETRY-BASED SCORING SYSTEM SOUNDARYA RAVI 5:00-7:00 PM
MHL-425 F CLINICOPATHOLOGICAL PROFILE, CYTOGENETICS AND PROGNOSTIC RISK SCORING OF MYELODYSPLASTIC SYNDROME . AKRITI KHARE 5:00-7:00 PM
MHL-426 F UTILITY OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF MALIGNANT MYELONECROSIS: EXPERIENCE ON 40 CASES FROM A SINGLE TERTIARY CENTRE. CHINMAYEE PANIGRAHI 5:00-7:00 PM
MHL-427 G ACUTE MYELOID NEOPLASM WITH MEGAKARYOBLASTIC DIFFERENTIATION (M7) : MORPHOLOGIC AND IMMUNOPHENOTYPIC CHARACTERISTICS OF 14 CASES FROM A SINGLE TERTIARY CARE CENTER PRAPTI ACHARYA 5:00-7:00 PM
MHL-428 G ACUTE MYELOID LEUKAEMIA WITH RAM IMMUNOPHENOTYPE: A RARE CASE REPORT PARAMITA MUKHERJEE 5:00-7:00 PM
MHL-429 G PREVALENCE OF INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21 IN INDIAN PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A PILOT STUDY CHETAN AGARWAL 5:00-7:00 PM
MHL-430 G SPECTRUM OF LYMPHOMAS INVOLVING BONE MARROW: A 3 YEARS STUDY DIPIKA CHAUBEY 5:00-7:00 PM
MHL-431 G ABERRANT IMMUNOPHENOTYPES- PREDICTIVE TOOL FOR PROGNOSIS IN ACUITE LEUKEMIA SUBHRASMITA DASH 5:00-7:00 PM
MHL-432 G MUTATION PROFILING IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS MEGHA SUBHANGINI 5:00-7:00 PM
MH-501 G FIRST CRYO-EM STRUCTURE OF THE NATIVE COAGULATION FACTOR XIII COMPLEX STRUCTURE AT 2.68 Å RESOLUTION SNEHA SINGH 5:00-7:00 PM
MH-502 G COMPARATIVE EFFECT OF TKIS ON PLATELET FUNCTION AND BLEEDING MANIFESTATION AMONG CML-CP PATIENTS IPSITA CHAKRABORTY 5:00-7:00 PM
MH-503 G STANDARIZATION AND VALIDATION OF DIGITAL DROPLET PCR (DDPCR) FOR CBFB-MYH11 MRD MONITORING IN ACUTE MYELOID LUEKEMIA POONAM DAS 5:00-7:00 PM
MH-504 G NEXT-GENERATION SEQUENCING BASED GENOMIC PROFILING OF ACUTE MYELOID LEUKEMIA IN PEDIATRIC POPULATION – A SINGLE CENTRE EXPERIENCE. PRAKHAR GUPTA 5:00-7:00 PM
MH-505 G A COMPARATIVE STUDY ON INTERNAL TANDEM DUPLICATION IN FLT3 GENE BY PCR-FRAGMENT ANALYSIS AND NGS. SAGAR UPADHYAY 5:00-7:00 PM
MH-506 G ROLE OF PTBP2 IN CML DISEASE PROGRESSION BY REGULATING TLS DNA REPAIR SYSTEM. SHRISTI LAMA 5:00-7:00 PM
MH-507 H BCP-ALL WITH DUX4::IGH - A NOVEL SUBTYPE OF B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL) PRASANNA BHANSHE 5:00-7:00 PM
MH-508 H PROFILING BETA THALASSEMIA MUTATIONS IN A TERTIARY HEALTH CARE CENTRE SHYLA SHYLA 5:00-7:00 PM
MH-509 H PREVALENCE AND SPECTRUM OF TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN CHRONIC MVELOID LEUKEMIA PATIENTS BEING TREATED WITH TYROSINE KINASE INHIBITORS. KUSUM GUPTA 5:00-7:00 PM
MH-510 H MOLECULAR SPECTRUM OF BETA- THALASSEMIA MUTATIONS IN A TERTIARY CARE CENTRE IN SOUTHERN ODISHA, INDIA. SNEHALATA PRADHAN 5:00-7:00 PM
MH-511 H THE GENOMIC LANDSCAPE OF PEDIATRIC MYELODYSPLASTIC NEOPLASMS (MDS): A SINGLE CENTER STUDY SEEMA BISWAS 5:00-7:00 PM
MH-512 H FLT3 MUTATION IN CASES OF AML IN TERTIARY HEALTH CARE CENTER. SAMSKRUTI PATNAIK 5:00-7:00 PM
MH-513 H ANALYSIS OF BCR-ABL1 IN PATIENTS WITH LEUKEMIA SHEETAL SABAT 5:00-7:00 PM
MH-514 H PRENATAL DIAGNOSIS OF HEMOGLOBINOPATHIES - EXPERIENCE FROM A SINGLE GOVT HOSPITAL IN EASTERN INDIA CHINMAYA BAL 5:00-7:00 PM
MH-515 H JAK2 MUTATIONS IN DE NOVO ACUTE MYELOID LEUKEMIA (AML): CLINICAL, LABORATORY AND GENOMIC CORRELATES SHADMA SHAHIN 5:00-7:00 PM
MH-516 H MOLECULAR ANALYSIS OF PATIENTS REFERRED FOR ELEVATED HEMOGLOBIN LEVELS – A TERTIARY CARE CENTER EXPERIENCE BISWAJIT MOHANTY 5:00-7:00 PM
MH-517 H SPECTRUM OF MOLECULAR MUTATIONS AMONG THE BETA THALASSAEMIA PATIENS IN EASTERN PARTS OF ODISHA BISNU DASH 5:00-7:00 PM
MH-518 H MUTATIONAL LANDSCAPE IN AML -A SINGLE INSTITUTION BASED STUDY MUKTA KUMARI 5:00-7:00 PM